Franken MG - Search Results

1

Stage-specific trends in incidence and survival of cutaneous melanoma in the Netherlands (2003-2018): A nationwide population-based study.

Leeneman B, Schreuder K, Uyl-de Groot CA, van Akkooi ACJ, Haanen JBAG, Wakkee M, Franken MG, Louwman MWJ. Leeneman B, et al. Among authors: franken mg. Eur J Cancer. 2021 Sep;154:111-119. doi: 10.1016/j.ejca.2021.06.007. Epub 2021 Jul 10. Eur J Cancer. 2021. PMID: 34256280 Free article.

2

The unit costs of inpatient hospital days, outpatient visits, and daycare treatments in the fields of oncology and hematology.

Tan SS, Van Gils CW, Franken MG, Hakkaart-van Roijen L, Uyl-de Groot CA. Tan SS, et al. Among authors: franken mg. Value Health. 2010 Sep-Oct;13(6):712-9. doi: 10.1111/j.1524-4733.2010.00740.x. Epub 2010 Jun 7. Value Health. 2010. PMID: 20561330 Free article.

3

Practical feasibility of outcomes research in oncology: lessons learned in assessing drug use and cost-effectiveness in The Netherlands.

Franken MG, van Gils CW, Gaultney JG, Delwel GO, Goettsch W, Huijgens PC, Steenhoek A, Punt CJ, Koopman M, Redekop WK, Uyl-de Groot CA. Franken MG, et al. Eur J Cancer. 2013 Jan;49(1):8-16. doi: 10.1016/j.ejca.2012.06.010. Epub 2012 Jul 16. Eur J Cancer. 2013. PMID: 22809557

4

Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents.

Gaultney JG, Franken MG, Tan SS, Redekop WK, Huijgens PC, Sonneveld P, Uyl-de Groot CA. Gaultney JG, et al. Among authors: franken mg. J Clin Pharm Ther. 2013 Feb;38(1):41-7. doi: 10.1111/jcpt.12020. Epub 2012 Nov 6. J Clin Pharm Ther. 2013. PMID: 23126374

5

Policymaker, please consider your needs carefully: does outcomes research in relapsed or refractory multiple myeloma reduce policymaker uncertainty regarding value for money of bortezomib?

Franken MG, Gaultney JG, Blommestein HM, Huijgens PC, Sonneveld P, Redekop WK, Uyl-de Groot CA. Franken MG, et al. Value Health. 2014 Mar;17(2):245-53. doi: 10.1016/j.jval.2013.12.009. Value Health. 2014. PMID: 24636383 Free article. Clinical Trial.

6

Access to expensive cancer drugs in Dutch daily practice: should we be concerned?

Blommestein HM, Franken MG, Verelst SG, van Agthoven M, Huijgens PC, Uyl-de Groot CA. Blommestein HM, et al. Among authors: franken mg. Neth J Med. 2014 May;72(4):235-41. Neth J Med. 2014. PMID: 24829184 Free article.

7

Experience with outcomes research into the real-world effectiveness of novel therapies in Dutch daily practice from the context of conditional reimbursement.

Gaultney JG, Franken MG, Uyl-de Groot CA, Redekop WK, Huijgens PC, van der Holt B, Lokhorst HM, Sonneveld P. Gaultney JG, et al. Among authors: franken mg. Health Policy. 2015 Feb;119(2):186-94. doi: 10.1016/j.healthpol.2014.11.010. Epub 2014 Nov 22. Health Policy. 2015. PMID: 25476554

8

A practical guide for using registry data to inform decisions about the cost effectiveness of new cancer drugs: lessons learned from the PHAROS registry.

Blommestein HM, Franken MG, Uyl-de Groot CA. Blommestein HM, et al. Among authors: franken mg. Pharmacoeconomics. 2015 Jun;33(6):551-60. doi: 10.1007/s40273-015-0260-4. Pharmacoeconomics. 2015. PMID: 25644460 Free PMC article.

9

The Importance of Long-Term Surveillance of Stage IB Melanomas: Unexpectedly Low Survival Subsequent to Recurrence.

Leeneman B, Franken MG, Blommestein HM, van Gils CW, van der Meijde E, Wouters MW, Plaisier PW, Kruit WH, van Ruth S, Ten Tije AJ, Hendriks MP, Coupe VM, Uyl-de Groot CA. Leeneman B, et al. Among authors: franken mg. Value Health. 2014 Nov;17(7):A618-9. doi: 10.1016/j.jval.2014.08.2187. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202168 Free article. No abstract available.

10

Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands.

Jochems A, Schouwenburg MG, Leeneman B, Franken MG, van den Eertwegh AJ, Haanen JB, Gelderblom H, Uyl-de Groot CA, Aarts MJ, van den Berkmortel FW, Blokx WA, Cardous-Ubbink MC, Groenewegen G, de Groot JW, Hospers GA, Kapiteijn E, Koornstra RH, Kruit WH, Louwman MW, Piersma D, van Rijn RS, Ten Tije AJ, Vreugdenhil G, Wouters MW, van der Hoeven JJ. Jochems A, et al. Among authors: franken mg. Eur J Cancer. 2017 Feb;72:156-165. doi: 10.1016/j.ejca.2016.11.021. Epub 2016 Dec 25. Eur J Cancer. 2017. PMID: 28030784

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters